The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Coronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival
Abstract
BACKGROUND Coronary artery disease (CAD) is common in lung transplant candidates and may require revascularization before or at the time of their transplant. We reviewed the survival of lung transplant recipients with coronary artery disease requiring surgical intervention (CAD-CABG) and those who did not (CAD-NoCABG) at the time of transplant, compared to a cohort with no CAD (NoCAD). METHODS We conducted a retrospective cohort study of adult patients transplanted in our program between 2004-2013. Our primary outcome was the association between 3-way CAD status (CAD-CABG, CAD-NoCABG, NoCAD) and overall retransplant-free survival via proportional hazards modelling, adjusting for age, gender and transplant indication. Secondary endpoints included 1-year survival, survival by Kaplan-Meier analysis, duration of ventilation, ICU stay and hospitalization. RESULTS 333 patients underwent transplant during the study timeframe. 24 (7%) had CAD requiring CABG, 82 (25%) had CAD not requiring CABG and the remaining 227 had no CAD. 3-way CAD status was not associated with overall retransplant-free survival after adjustment for age, gender and transplant indication. Duration of mechanical ventilation, ICU stay and hospitalization were longer in both CAD groups compared to the NoCAD group. CONCLUSIONS CAD status does not impact overall retransplant-free survival, despite greater perioperative complexity. Prospective studies comparing treatment strategies in these patient groups are warrante…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple retrospective studies over the past 5 years have shown that patients with mild to moderate CAD or those who have undergone revascularization for CAD may not have worse survival compared to patients without CAD.(23–26)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [23]
In the citing paper
“CAD was not associated with worse survival for patients undergoing percutaneous coronary intervention with stent placement prior to lung transplant or coronary artery bypass grafting (CABG) at the time of lung transplant.(23)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [23]
In the citing paper
“there was no significant difference in the survival rate of patients with mild to moderate CAD or who underwent coronary intervention before surgery”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [18]
In the citing paper
“PVD is not considered an absolute contraindication”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [18]
Citations
Cites
Serruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 3×
“Diabetes 26 (8) 1 (4) 9 (11) 16 (7) 0.”
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Yusen, R. D., Edwards, L. B., Dipchand, A. I., Goldfarb, S. B., Kucheryavaya, A. Y., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., & Stehlik, J. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.09.001 · Cited by 596
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.07.044 · Cited by 304
Machuca, T. N., Collaud, S., Mercier, O., Cheung, M., Cunningham, V., Kim, S. J., Azad, S., Singer, L., Yasufuku, K., de Perrot, M., et al. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.039 · Cited by 248 · cited 2×
“1 to 10 pack years 41 (12) 3 (12) 9 (11) 29 (13)”
Ius, F., Kuehn, C., Tudorache, I., Sommer, W., Avsar, M., Boethig, D., Fuehner, T., Gottlieb, J., Hoeper, M., Haverich, A., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.07.095 · Cited by 222 · cited 2×
“1 to 10 pack years 41 (12) 3 (12) 9 (11) 29 (13)”
Pretransplant frailty is associated with decreased survival after lung transplantation
Wilson, M. E., Vakil, A. P., Kandel, P., Undavalli, C., Dunlay, S. M., & Kennedy, C. C. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.014 · Cited by 151 · cited 4×
“11 to 20 pack years 31 (9) 2 (8) 12 (15) 17 (8)”
InfluentialLiu, J. Z., Jackson, K., Weinkauf, J. G., Kapasi, A., Hirji, A. S., Meyer, S. R., Mullen, J. C., Nagendran, J., Lien, D. C., & Halloran, K. M. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.02.014 · Cited by 89 · cited 1×
“ICU LOS (days), median (n miss = 1) 7 (4-15) 12 (7-27) 8 (5-21) 7 (4-11) 0.”
Self-citationThe effect of calcineurin inhibitors on endothelial function in renal transplant recipients
Oflaz, H., Türkmen, A., Kazancıoğlu, R., Kayacan, S. M., Bunyak, B., Gençhallaç, H., Erol, B., Mercanoğlu, F., Umman, S., & Sever, M. Ş. (2003) · Clinical Transplantation · doi:10.1034/j.1399-0012.2003.00030.x · Cited by 59 · cited 3×
“0001 Mild 66 (20) 6 (25) 60 (73) 0 (0) Moderate 21 (6) 7 (29) 14 (17) 0 (0) Severe 19 (6) 11 (46) 8 (10) 0 (0) No.”
Coronary Revascularization in Lung Transplant Recipients With Concomitant Coronary Artery Disease
Castleberry, A. W., Martin, J. T., Osho, A. A., Hartwig, M. G., Hashmi, Z. A., Zanotti, G., Shaw, L. K., Williams, J. B., Lin, S. S., & Davis, R. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12435 · Cited by 58 · cited 2×
“1 to 10 pack years 41 (12) 3 (12) 9 (11) 29 (13)”
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
“CAD was not associated with worse survival for patients undergoing percutaneous coronary intervention with stent placement prior to lung transplant or coronary artery bypass grafting (CABG) at the time of lung transplant.(23) In those patients with a history of prior”
Current trends in candidate selection, contraindications, and indications for lung transplantation
Arjuna, A., Olson, M. T., & Walia, R. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-09 · Cited by 35
“In a more recent series of 333 patients who underwent lung transplant between 2004 and 2013, no association was seen between 3-way coronary artery disease (CAD) status (CAD-CABG, CAD-No CABG, No CAD) and overall re-transplant-free survival after adjusting for age, gender, and transplant indication (42).”
BackgroundEhrsam, J. P., Schuurmans, M. M., Laager, M., Opitz, I., & İnci, İ. (2022) · Transplant International · doi:10.3389/ti.2022.10451 · Cited by 21
Indications for Lung Transplantation and Patient Selection
Son, J., & Shin, C. (2022) · Journal of Chest Surgery · doi:10.5090/jcs.22.057 · Cited by 10
“As patients with PVD are more likely to have concomitant vascular disease, which can be a problem, various preoperative evaluations are necessary, and a cautious approach must be taken [17-20].”
BackgroundLung transplant and severe coronary artery disease: results from a single-centre experience
Franz, M., Siemeni, T., Aburahma, K., Iablonskii, P., Poyanmehr, R., Avsar, M., Bobylev, D., Sommer, W., Boethig, D., Greer, M., et al. (2022) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezac348 · Cited by 9
Metadata
- Authors
- Halloran, K., Hirji, A., Li, D., Jackson, K., Kapasi, A., Meyer, S., Mullen, J., Lien, D., & Weinkauf, J.
- Affiliations
- Alberta Health Services (CA)
- Lung Transplant Program, Alberta Health Services, Edmonton, AB, Canada.
- Corresponding author
- Halloran, Kieran
- Venue
- Transplantation
- Published
- 2019-10
- Volume
- 103
- Issue
- 10
- Pages
- 2190-2195
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2918604280
- Cited by
- 21
- References
- 17
- Citations by year
- 2026: 4 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- coronary artery disease, coronary artery bypass grafting, lung transplantation, mechanical ventilation duration, ICU length of stay, hospitalization, transplant candidates
- MeSH terms
- Adult, Aged, Coronary Artery Bypass, Coronary Artery Disease, Female, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Respiratory Insufficiency, Retrospective Studies, Risk Factors, Comorbidity, Lung Transplantation, Treatment Outcome, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival. https://app.cochat.ai/papers/10.1097/tp.0000000000002609
- The paper
- Halloran, K., Hirji, A., Li, D., Jackson, K., Kapasi, A., Meyer, S., Mullen, J., Lien, D., & Weinkauf, J. (2019). Coronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival. Transplantation. https://doi.org/10.1097/tp.0000000000002609
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.